Lowey Dannenberg P.C. is investigating Hims & Hers Health, Inc. for potential violations of federal securities laws. The investigation follows a July 29, 2026 complaint by the Federal Trade Commission, joined by Utah and California, alleging deceptive practices including charging consumers before provider approval, unauthorized recurring subscriptions, difficult cancellation processes, and sharing sensitive health data with platforms like Meta and Snap. Hims & Hers stock fell $3.05 per share, or approximately 10.40%, during intraday trading on July 29, 2026. The law firm is examining whether the company and its executives provided accurate and complete information to investors.
Hims Hers Health IncFTC complaint and investigation into deceptive practices
